F7806
间氟氯苄
96%
别名:
3-氟氯苄, 3-氟苄氯
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
FC6H4CH2Cl
化学文摘社编号:
分子量:
144.57
EC Number:
207-264-8
UNSPSC Code:
12352100
PubChem Substance ID:
Beilstein/REAXYS Number:
742265
MDL number:
Assay:
96%
Form:
liquid
InChI key
XBDXMDVEZLOGMC-UHFFFAOYSA-N
InChI
1S/C7H6ClF/c8-5-6-2-1-3-7(9)4-6/h1-4H,5H2
SMILES string
Fc1cccc(CCl)c1
assay
96%
form
liquid
density
1.194 g/mL at 25 °C (lit.)
正在寻找类似产品? 访问 产品对比指南
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1 - Skin Corr. 1B
存储类别
3 - Flammable liquids
wgk
WGK 3
flash_point_f
159.8 °F - closed cup
flash_point_c
71 °C - closed cup
ppe
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
法规信息
新产品
此项目有
William L Scott et al.
Journal of combinatorial chemistry, 11(1), 14-33 (2008-12-25)
Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computational stages of D(3) is the global rehearsal of prospective reagents and
Steffen Bugge et al.
European journal of medicinal chemistry, 94, 175-194 (2015-03-15)
An approach for optimization of epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors using truncated thienopyrimidine structures combined with enzymatic assay has been evaluated. This was done by synthesis and EGFR activity measurement of a series of fragment structures and
William L Scott et al.
Journal of combinatorial chemistry, 11(1), 34-43 (2008-12-25)
For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducibly make new, high quality, molecules with potential for biological activity. This article reports
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持